NEW YORK ( TheStreet) -- Welcome to Don Dion's "ETF Winners and Losers." Be sure to stop by throughout the week to find out which ETFs are gaining or losing.
Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.
Your retirement portfolio could get a salutary boost from biotech stocks along with ETFs in the sector that have generated large returns in 2016, producing double digit-gains.
When an activist investor such as Carl Icahn takes a position in a stock, other investors rush in and bid up the share price. That's not always a good dea.